Cedazuridine and Decitabine
Brand name: Inqovi
Cedazuridine and Decitabine comes in 2 pill versions in our database, in 1 strength, from 2 manufacturers. Check the imprint to tell them apart.
Cedazuridine and Decitabine pill images
100 mg / 35 mg 2 pills
What is Cedazuridine and Decitabine used for?
Cedazuridine and Decitabine is a nucleoside metabolic inhibitor.
- Medicine type
- Nucleoside metabolic inhibitor
Official uses from the US prescribing label
Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
INQOVI is indicated for treatment of adult patients with myelodysplastic syndromes (MDS), including previously treated and untreated, de novo and secondary MDS with the following French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia [CMML]) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
Acute Myeloid Leukemia
INQOVI is indicated in combination with venetoclax for the treatment of newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.
From the FDA-approved label on DailyMed (published May 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.